“Real-World Effectiveness of Ixekizumab in Mild, Moderate, and Severe Psoriasis: The Patient Perspective”. 2023. SKIN The Journal of Cutaneous Medicine 7 (3): s202. https://doi.org/10.25251/skin.7.supp.202.